MHRA (UK)Original article
Class 4 Medicines Defect Notification: Martindale Pharmaceuticals Ltd, Clobazam Martindale Pharma 5 mg/5 mL and 10 mg/5 mL Oral Suspension 150ml, EL(26)A/38
RegulatoryClobazam Martindale Pharma 5 mg/5 mL Oral Suspension 150mlClobazam Martindale Pharma 10 mg/5 mL Oral Suspension 150mlNegative
AI Analysis
Summary
Martindale Pharmaceuticals notified the MHRA of a barcode error affecting certain batches of Clobazam 5mg/5mL and 10mg/5mL oral suspension, classified as a Class 4 medicines defect.
Outcome Details
Class 4 Medicines Defect Notification for linear barcode error on certain batches
Importance:2/10
Sentiment:
-0.40
product defectbarcode errorMHRA notificationClass 4 defectmanufacturing issue
Read the original article
Published by MHRA (UK) on September 17, 2026 11:59 AM